Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Oncology

P2.17-12 Eliminating Radiation Resistance of Non-Small Cell Lung Cancer by DHA Trough Abrogating Immunity Escaping via Inhibiting PD-L1 Expression

Journal of Thoracic Oncology

English

P088 Distribution of Different HER2 Mutations and Their Impact on Clinical Responses to Afatinib in HER2-Mutant Lung Cancer

Journal of Thoracic Oncology

English

MA25.06 RPA Analysis for Oligometastatic Non-Small Cell Lung Cancer: Smoking Combine T3/4 Patients May Not Be Benefit From Local Consolidative Treatment

Journal of Thoracic Oncology

English

P1.01-55 Unique Genetic Profiles From Cerebrospinal Fluid Could Predict Survival of EGFR-Mutant NSCLC With Leptomeningeal Metastases

Journal of Thoracic Oncology

English

P1.01-65 PII of Pemetrexed or Pemetrexed Plus Bevacizumab for Previously Untreated Elderly (>=75) Non-Squamous NSCLC (LOGIK1201)

Journal of Thoracic Oncology

English

P20 Molecular Characterization of Non–Small Cell Lung Cancer (NSCLC) Patients by Next Generation Sequencing: Preliminary Data

Journal of Thoracic Oncology

English

P3.cr-34 a Giant Ganglioneuroma of the Thoracic Spine

Journal of Thoracic Oncology

English

MA12.02 Quality of Life Following Pleurectomy Decortication and Extrapleural Pneumonectomy for Pleural Malignant Mesothelioma

Journal of Thoracic Oncology

English

OA13.07 Survival Outcomes After Whole Brain Radiotherapy for Brain Metastases in Elderly Patients With Newly Diagnosed Metastatic Small Cell Carcinoma.

Journal of Thoracic Oncology

English

P3.04-08 Identifying Resistance to Immune Checkpoint Inhibitors by Screening for PD-L1 and MHC I Expression on CTCs in PTS With NSCLC

Journal of Thoracic Oncology

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Oncology

P2.17-12 Eliminating Radiation Resistance of Non-Small Cell Lung Cancer by DHA Trough Abrogating Immunity Escaping via Inhibiting PD-L1 Expression

P088 Distribution of Different HER2 Mutations and Their Impact on Clinical Responses to Afatinib in HER2-Mutant Lung Cancer

MA25.06 RPA Analysis for Oligometastatic Non-Small Cell Lung Cancer: Smoking Combine T3/4 Patients May Not Be Benefit From Local Consolidative Treatment

P1.01-55 Unique Genetic Profiles From Cerebrospinal Fluid Could Predict Survival of EGFR-Mutant NSCLC With Leptomeningeal Metastases

P1.01-65 PII of Pemetrexed or Pemetrexed Plus Bevacizumab for Previously Untreated Elderly (>=75) Non-Squamous NSCLC (LOGIK1201)

P20 Molecular Characterization of Non–Small Cell Lung Cancer (NSCLC) Patients by Next Generation Sequencing: Preliminary Data

P3.cr-34 a Giant Ganglioneuroma of the Thoracic Spine

MA12.02 Quality of Life Following Pleurectomy Decortication and Extrapleural Pneumonectomy for Pleural Malignant Mesothelioma

OA13.07 Survival Outcomes After Whole Brain Radiotherapy for Brain Metastases in Elderly Patients With Newly Diagnosed Metastatic Small Cell Carcinoma.

P3.04-08 Identifying Resistance to Immune Checkpoint Inhibitors by Screening for PD-L1 and MHC I Expression on CTCs in PTS With NSCLC